GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems

B. K.B. Lee, C. P. Gan, J. K. Chang, J. L. Tan, M. Z. Fadlullah, Z. A. Abdul Rahman, S. S. Prime, J. S. Gutkind, C. S. Liew, T. F. Khang, Aik-Choon Tan, S. C. Cheong

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Head and neck cancer (HNC)–derived cell lines represent fundamental models for studying the biological mechanisms underlying cancer development and precision therapies. However, mining the genomic information of HNC cells from available databases requires knowledge on bioinformatics and computational skill sets. Here, we developed a user-friendly web resource for exploring, visualizing, and analyzing genomics information of commonly used HNC cell lines. We populated the current version of GENIPAC with 44 HNC cell lines from 3 studies: ORL Series, OPC-22, and H Series. Specifically, the mRNA expressions for all the 3 studies were derived with RNA-seq. The copy number alterations analysis of ORL Series was performed on the Genome Wide Human Cytoscan HD array, while copy number alterations for OPC-22 were derived from whole exome sequencing. Mutations from ORL Series and H Series were derived from RNA-seq information, while OPC-22 was based on whole exome sequencing. All genomic information was preprocessed with customized scripts and underwent data validation and correction through data set validator tools provided by cBioPortal. The clinical and genomic information of 44 HNC cell lines are easily assessable in GENIPAC. The functional utility of GENIPAC was demonstrated with some of the genomic alterations that are commonly reported in HNC, such as TP53, EGFR, CCND1, and PIK3CA. We showed that these genomic alterations as reported in The Cancer Genome Atlas database were recapitulated in the HNC cell lines in GENIPAC. Importantly, genomic alterations within pathways could be simultaneously visualized. We developed GENIPAC to create access to genomic information on HNC cell lines. This cancer omics initiative will help the research community to accelerate better understanding of HNC and the development of new precision therapeutic options for HNC treatment. GENIPAC is freely available at http://genipac.cancerresearch.my/.

Original languageEnglish
Pages (from-to)909-916
Number of pages8
JournalJournal of Dental Research
Volume97
Issue number8
DOIs
Publication statusPublished - 2018 Jul 1
Externally publishedYes

Fingerprint

Head and Neck Neoplasms
Cell Line
Exome
Databases
RNA
Biological Models
Neoplasms
Access to Information
Atlases
Human Genome
Genomics
Computational Biology
Genome
Messenger RNA
Mutation
Therapeutics

Keywords

  • bioinformatics
  • biomarkers
  • cancer biology
  • gene expression
  • genomics
  • oral carcinogenesis

ASJC Scopus subject areas

  • Dentistry(all)

Cite this

Lee, B. K. B., Gan, C. P., Chang, J. K., Tan, J. L., Fadlullah, M. Z., Abdul Rahman, Z. A., ... Cheong, S. C. (2018). GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems. Journal of Dental Research, 97(8), 909-916. https://doi.org/10.1177/0022034518759038

GENIPAC : A Genomic Information Portal for Head and Neck Cancer Cell Systems. / Lee, B. K.B.; Gan, C. P.; Chang, J. K.; Tan, J. L.; Fadlullah, M. Z.; Abdul Rahman, Z. A.; Prime, S. S.; Gutkind, J. S.; Liew, C. S.; Khang, T. F.; Tan, Aik-Choon; Cheong, S. C.

In: Journal of Dental Research, Vol. 97, No. 8, 01.07.2018, p. 909-916.

Research output: Contribution to journalArticle

Lee, BKB, Gan, CP, Chang, JK, Tan, JL, Fadlullah, MZ, Abdul Rahman, ZA, Prime, SS, Gutkind, JS, Liew, CS, Khang, TF, Tan, A-C & Cheong, SC 2018, 'GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems', Journal of Dental Research, vol. 97, no. 8, pp. 909-916. https://doi.org/10.1177/0022034518759038
Lee BKB, Gan CP, Chang JK, Tan JL, Fadlullah MZ, Abdul Rahman ZA et al. GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems. Journal of Dental Research. 2018 Jul 1;97(8):909-916. https://doi.org/10.1177/0022034518759038
Lee, B. K.B. ; Gan, C. P. ; Chang, J. K. ; Tan, J. L. ; Fadlullah, M. Z. ; Abdul Rahman, Z. A. ; Prime, S. S. ; Gutkind, J. S. ; Liew, C. S. ; Khang, T. F. ; Tan, Aik-Choon ; Cheong, S. C. / GENIPAC : A Genomic Information Portal for Head and Neck Cancer Cell Systems. In: Journal of Dental Research. 2018 ; Vol. 97, No. 8. pp. 909-916.
@article{72a0cdebc7154abea96416e4af7645b5,
title = "GENIPAC: A Genomic Information Portal for Head and Neck Cancer Cell Systems",
abstract = "Head and neck cancer (HNC)–derived cell lines represent fundamental models for studying the biological mechanisms underlying cancer development and precision therapies. However, mining the genomic information of HNC cells from available databases requires knowledge on bioinformatics and computational skill sets. Here, we developed a user-friendly web resource for exploring, visualizing, and analyzing genomics information of commonly used HNC cell lines. We populated the current version of GENIPAC with 44 HNC cell lines from 3 studies: ORL Series, OPC-22, and H Series. Specifically, the mRNA expressions for all the 3 studies were derived with RNA-seq. The copy number alterations analysis of ORL Series was performed on the Genome Wide Human Cytoscan HD array, while copy number alterations for OPC-22 were derived from whole exome sequencing. Mutations from ORL Series and H Series were derived from RNA-seq information, while OPC-22 was based on whole exome sequencing. All genomic information was preprocessed with customized scripts and underwent data validation and correction through data set validator tools provided by cBioPortal. The clinical and genomic information of 44 HNC cell lines are easily assessable in GENIPAC. The functional utility of GENIPAC was demonstrated with some of the genomic alterations that are commonly reported in HNC, such as TP53, EGFR, CCND1, and PIK3CA. We showed that these genomic alterations as reported in The Cancer Genome Atlas database were recapitulated in the HNC cell lines in GENIPAC. Importantly, genomic alterations within pathways could be simultaneously visualized. We developed GENIPAC to create access to genomic information on HNC cell lines. This cancer omics initiative will help the research community to accelerate better understanding of HNC and the development of new precision therapeutic options for HNC treatment. GENIPAC is freely available at http://genipac.cancerresearch.my/.",
keywords = "bioinformatics, biomarkers, cancer biology, gene expression, genomics, oral carcinogenesis",
author = "Lee, {B. K.B.} and Gan, {C. P.} and Chang, {J. K.} and Tan, {J. L.} and Fadlullah, {M. Z.} and {Abdul Rahman}, {Z. A.} and Prime, {S. S.} and Gutkind, {J. S.} and Liew, {C. S.} and Khang, {T. F.} and Aik-Choon Tan and Cheong, {S. C.}",
year = "2018",
month = "7",
day = "1",
doi = "10.1177/0022034518759038",
language = "English",
volume = "97",
pages = "909--916",
journal = "Journal of Dental Research",
issn = "0022-0345",
publisher = "SAGE Publications Inc.",
number = "8",

}

TY - JOUR

T1 - GENIPAC

T2 - A Genomic Information Portal for Head and Neck Cancer Cell Systems

AU - Lee, B. K.B.

AU - Gan, C. P.

AU - Chang, J. K.

AU - Tan, J. L.

AU - Fadlullah, M. Z.

AU - Abdul Rahman, Z. A.

AU - Prime, S. S.

AU - Gutkind, J. S.

AU - Liew, C. S.

AU - Khang, T. F.

AU - Tan, Aik-Choon

AU - Cheong, S. C.

PY - 2018/7/1

Y1 - 2018/7/1

N2 - Head and neck cancer (HNC)–derived cell lines represent fundamental models for studying the biological mechanisms underlying cancer development and precision therapies. However, mining the genomic information of HNC cells from available databases requires knowledge on bioinformatics and computational skill sets. Here, we developed a user-friendly web resource for exploring, visualizing, and analyzing genomics information of commonly used HNC cell lines. We populated the current version of GENIPAC with 44 HNC cell lines from 3 studies: ORL Series, OPC-22, and H Series. Specifically, the mRNA expressions for all the 3 studies were derived with RNA-seq. The copy number alterations analysis of ORL Series was performed on the Genome Wide Human Cytoscan HD array, while copy number alterations for OPC-22 were derived from whole exome sequencing. Mutations from ORL Series and H Series were derived from RNA-seq information, while OPC-22 was based on whole exome sequencing. All genomic information was preprocessed with customized scripts and underwent data validation and correction through data set validator tools provided by cBioPortal. The clinical and genomic information of 44 HNC cell lines are easily assessable in GENIPAC. The functional utility of GENIPAC was demonstrated with some of the genomic alterations that are commonly reported in HNC, such as TP53, EGFR, CCND1, and PIK3CA. We showed that these genomic alterations as reported in The Cancer Genome Atlas database were recapitulated in the HNC cell lines in GENIPAC. Importantly, genomic alterations within pathways could be simultaneously visualized. We developed GENIPAC to create access to genomic information on HNC cell lines. This cancer omics initiative will help the research community to accelerate better understanding of HNC and the development of new precision therapeutic options for HNC treatment. GENIPAC is freely available at http://genipac.cancerresearch.my/.

AB - Head and neck cancer (HNC)–derived cell lines represent fundamental models for studying the biological mechanisms underlying cancer development and precision therapies. However, mining the genomic information of HNC cells from available databases requires knowledge on bioinformatics and computational skill sets. Here, we developed a user-friendly web resource for exploring, visualizing, and analyzing genomics information of commonly used HNC cell lines. We populated the current version of GENIPAC with 44 HNC cell lines from 3 studies: ORL Series, OPC-22, and H Series. Specifically, the mRNA expressions for all the 3 studies were derived with RNA-seq. The copy number alterations analysis of ORL Series was performed on the Genome Wide Human Cytoscan HD array, while copy number alterations for OPC-22 were derived from whole exome sequencing. Mutations from ORL Series and H Series were derived from RNA-seq information, while OPC-22 was based on whole exome sequencing. All genomic information was preprocessed with customized scripts and underwent data validation and correction through data set validator tools provided by cBioPortal. The clinical and genomic information of 44 HNC cell lines are easily assessable in GENIPAC. The functional utility of GENIPAC was demonstrated with some of the genomic alterations that are commonly reported in HNC, such as TP53, EGFR, CCND1, and PIK3CA. We showed that these genomic alterations as reported in The Cancer Genome Atlas database were recapitulated in the HNC cell lines in GENIPAC. Importantly, genomic alterations within pathways could be simultaneously visualized. We developed GENIPAC to create access to genomic information on HNC cell lines. This cancer omics initiative will help the research community to accelerate better understanding of HNC and the development of new precision therapeutic options for HNC treatment. GENIPAC is freely available at http://genipac.cancerresearch.my/.

KW - bioinformatics

KW - biomarkers

KW - cancer biology

KW - gene expression

KW - genomics

KW - oral carcinogenesis

UR - http://www.scopus.com/inward/record.url?scp=85045055701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045055701&partnerID=8YFLogxK

U2 - 10.1177/0022034518759038

DO - 10.1177/0022034518759038

M3 - Article

AN - SCOPUS:85045055701

VL - 97

SP - 909

EP - 916

JO - Journal of Dental Research

JF - Journal of Dental Research

SN - 0022-0345

IS - 8

ER -